CD40 and atherosclerosis: In 2010, it was shown that CD40-TRAF6 signaling but not CD40-TRAF2/3/5 signaling is an important key player in activation of pro-inflammatory immune responses and in the development of atherosclerosis (Lutgens et al., 2010).